Pricing Log in Create free account

ENDRA Life Sciences Inc. (NDRA) vs T2 Biosystems, Inc. (TTOO)

ENDRA Life Sciences Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.7M against $6.5M — 1.2× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −559.5%) and the lower return on invested capital (−539.9% vs 0.00%). Across the 13 metrics below, ENDRA Life Sciences Inc. leads on 8 and T2 Biosystems, Inc. on 5.

Valuation

Metric NDRA TTOO Diagnostics & Research median
P/E n/m n/m 35.56
P/S 17.54 n/m 4.37
P/B 0.99 n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales 2.22 6.26 5.51
Earnings yield (133.33%) 0.00% (1.89%)
Free cash flow yield (124.95%) 0.00% (0.15%)

Profitability

Metric NDRA TTOO Diagnostics & Research median
Gross margin 0.00% (76.76%) 50.89%
Operating margin 0.00% (542.59%) (8.57%)
Net margin 0.00% (559.52%) (6.37%)
Free cash flow margin 0.00% (476.64%) 0.00%
Return on equity (152.04%) 277.61% (2.92%)
Return on assets (110.08%) (140.00%) (6.71%)
Return on invested capital (539.89%) 0.00% 0.00%

Growth

Metric NDRA TTOO Diagnostics & Research median
Revenue growth (TTM) — (30.19%) 7.69%
EPS growth (last fiscal year) 84.32% 98.44% 25.92%
Revenue growth, 5-year CAGR — (7.29%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NDRA TTOO Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 7.10 0.40 2.02
Net debt to EBITDA 0.14 0.32 0.70

Dividend

Metric NDRA TTOO Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric NDRA TTOO Diagnostics & Research median
Market cap 7.65m 6.48m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack